ClassID:

94745

C07D277/06 - CPC Classification

Classification description:

Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Recent Application in this class:
#1
20250333389
2025-10-30

PHARMACEUTICAL FOR THE INHIBITION OF CELLULAR PROTON PUMPS

#2
20250179037
2025-06-05

CRYSTALLINE FORM OF LEUCOGEN AND METHOD FOR PREPARATION THEREOF AND USE THEREOF

#3
20230416168
2023-12-28

N-HETEROCYCLIC COMPOUNDS USED AS NITRIFICATION INHIBITOR

#4
20230183786
2023-06-15

METHODS FOR IDENTIFYING AND MODULATING CO-OCCURANT CELLULAR PHENOTYPES

#5
20230044979
2023-02-09

ANIMAL CELL CULTURING METHOD

#6
20220324820
2022-10-13

METHODS AND COMPOSITIONS FOR GAMMA-GLUTAMYL CYCLE MODULATION

#7
20220259164
2022-08-18

USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT

#8
20220204540
2022-06-30

ESTERS OF NON- AROMATIC HETEROCYCLIC COMPOUNDS HAVING A NEMATOCIDAL ACTIVITY, THEIR AGRONOMIC COMPOSITIONS AND USE THEREOF

#9
20220073475
2022-03-10

5-MEMBERED HETEROARYL COMPOUNDS CONTAINING A HYDROXAMATE MOIETY AND THEIR USE

#10
20210387986
2021-12-16

Inhibitors of integrin alpha 2 beta 1 and methods of use

#11
20210323935
2021-10-21

ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF

#12
20210078947
2021-03-18

Therapeutic compounds and methods of use thereof

#13
20200347016
2020-11-05

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

#14
20200246286
2020-08-06

Imaging composition and uses thereof

#15
20200206149
2020-07-02

Inhibition of glutaminase C

#16
20200148636
2020-05-14

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

#17
20200009090
2020-01-09

Imaging composition and uses thereof

#18
20190359580
2019-11-28

Methods and compositions for gamma-glutamyl cycle modulation

#19
20190300478
2019-10-03

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

#20
20190194151
2019-06-27

ALPHA-AMINO ESTERS OF HYDROXYPROPYLTHIAZOLIDINE CARBOXAMIDE DERIVATIVE AND SALT FORM, CRYSTAL POLYMORPH THEREOF

#21
20190099392
2019-04-04

Imaging composition and uses thereof

#22
20190093154
2019-03-28

Methods for identifying and modulating co-occurant cellular phenotypes

#23
20190031607
2019-01-31

Therapeutic compounds and methods of use thereof

#24
20180312500
2018-11-01

ANTI-ALPHAVBETA1 INTEGRIN COMPOUNDS AND METHODS

#25
20180297944
2018-10-18

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

#26
20180265465
2018-09-20

Therapeutic compounds and methods of use thereof

#27
20180201591
2018-07-19

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

#28
20180193476
2018-07-12

Enzymatic conjugation of antibodies

#29
20180071402
2018-03-15

ENZYMATIC CONJUGATION OF POLYPEPTIDES

#30
20170326084
2017-11-16

Imaging composition and uses thereof

#31
20170283376
2017-10-05

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

#32
20170226070
2017-08-10

Methods and compositions for gamma-glutamyl cycle modulation

#33
20170190677
2017-07-06

Alpha-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof

#34
20170190662
2017-07-06

Therapeutic compounds and methods of use thereof

#35
20170066784
2017-03-09

Antimicrobial compounds

#36
20160376266
2016-12-29

Anti-alphavbeta1 integrin compounds and methods

#37
20160185795
2016-06-30

Urea derivatives and their use as fatty-acid binding protein (FABP) inhibitors

#38
20160060234
2016-03-03

Cysteine derivative

#39
20160031810
2016-02-04

Benzidine derivative, method for preparing same, and pharmaceutical composition containing benzidine derivative for treating liver disease caused by hepatitis C virus

#40
20150366776
2015-12-24

Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof

#41
20150322087
2015-11-12

Cephalosporin derivatives and methods of use

#42
20150289511
2015-10-15

Molecules that induce disease resistance and improve growth in plants

#43
20150017111
2015-01-15

Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use thereof

#44
20140356385
2014-12-04

Enzymatic conjugation of antibodies

#45
20140316105
2014-10-23

Method for modification of organic molecules

#46
20140275187
2014-09-18

Methods and compositions for gamma-glutamyl cycle modulation

#47
20140155365
2014-06-05

Compositions and methods for cytoprotection

#48
20140037564
2014-02-06

Compound having skin-whitening, anti-oxidizing and PPAR activities and medical use therefor

#49
20130189287
2013-07-25

Enzymatic conjugation of polypeptides

#50
20130095048
2013-04-18

Cysteine derivative

#51
20130058980
2013-03-07

Small molecule inhibitors of protein kinases

#52
20130035478
2013-02-07

Pyrrolysine analogs

#53
20130023539
2013-01-24

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

#54
20120329731
2012-12-27

THERAPEUTIC METHODS, COMPOSITIONS, AND COMPOUNDS

#55
20120258403
2012-10-11

Salt and photoresist composition comprising the same

#56
20120220610
2012-08-30

Inhibition of glutaminase C

#57
20120115918
2012-05-10

Anti-Viral Compounds

#58
20120077779
2012-03-29

Inhibitors of Fibroblast Activation Protein Alpha

#59
20120053222
2012-03-01

Novel Metabolic Disease Therapy

#60
20110275645
2011-11-10

Small molecules for inhibition of protein kinases

#61
20110224156
2011-09-15

Propionic acids, propionic acid esters, and related compounds

#62
20110184185
2011-07-28

Methods Of Preparing Thiazolidines

#63
20110118305
2011-05-19

COMPOUNDS

#64
20110112076
2011-05-12

SELECTIVE HYDROXAMIC ACID BASED MMP-12 AND MMP-13 INHIBITORS

#65
20110028462
2011-02-03

Niacin Receptor Agonists, compositions Containing Such Compounds and Methods of Treatment

#66
20100267634
2010-10-21

Anti-viral compounds

#67
20100249181
2010-09-30

HIV Protease Inhibiting Compounds

#68
20100228015
2010-09-09

PRODRUG DERIVATIVES OF ACIDS USING ALCOHOLS WITH HOMOTOPIC HYDROXY GROUPS AND METHODS FOR THEIR PREPARATION AND USE

#69
20100190791
2010-07-29

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

#70
20100190688
2010-07-29

Tetrapeptide analogs

#71
20100179119
2010-07-15

Inhibitors of integrin alpha2beta1 based on prolyl diaminopropionic acid scaffold

#72
20100130572
2010-05-27

Cytoskeletal active compounds, composition and use

#73
20100048570
2010-02-25

THIAZOLIDINE DERIVATIVES AND METHODS FOR THE PREPARATION THEREOF

#74
20100022605
2010-01-28

N-hydroxyamide derivatives possessing antibacterial activity

#75
20090233968
2009-09-17

Inhibitors of the α2β1/GPIa-IIa integrin

#76
20090221818
2009-09-03

Inhibitors of fibroblast activation protein alpha

#77
20090215749
2009-08-27

THIAZOLIDINE CARBOXAMIDE DERIVATIVES AS MODULATORS OF THE PROSTAGLANDIN F RECEPTOR

#78
20090197865
2009-08-06

THERAPEUTIC METHODS, COMPOSITIONS AND COMPOUNDS

#79
20090197861
2009-08-06

Inhibitors of integrin alpha2beta1 with modified urea moiety

#80
20090176847
2009-07-09

Dicyclooctane Derivatives, Preparation Processes and Medical Uses Thereof

#81
20090143446
2009-06-04

THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, METHODS OF MAKING, AND USES THEREOF

#82
20090042850
2009-02-12

Compositions and methods for cytoprotection

#83
20090030210
2009-01-29

Process for Producing Optically Active 2-Alkylcysteine, Derivative Thereof, and Processes for Production

#84
20080269206
2008-10-30

Cyclic and acyclic hydrazine derivatives compositions including them and uses thereof

#85
20080255213
2008-10-16

THIAZOLIDINONE AMIDES, THIAZOLIDINE CARBOXYLIC ACID AMIDES, AND SERINE AMIDES, INCLUDING POLYAMINE CONJUGATES THEREOF, AS SELECTIVE ANTI-CANCER AGENTS

#86
20080255094
2008-10-16

Thiazolidine carboxamide derivatives as modulators of the prostaglandin F receptor

#87
20080153892
2008-06-26

Inhibitors of glutaminyl cyclase

#88
20080108820
2008-05-08

Hemiasterlin Derivatives and Uses Thereof

#89
20080076735
2008-03-27

Cytoskeletal active compounds, composition and use

#90
20070259925
2007-11-08

DPP IV inhibitors

#91
20070254920
2007-11-01

Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use

#92
20070225344
2007-09-27

Sulfonamide derivatives to treat infection with hepatitis C virus

#93
20070155807
2007-07-05

Thiazolidinone amides, thiazolidine carboxylic acid amides, and serine amides, including polyamine conjugates thereof, as selective anti-cancer agents

#94
20070155705
2007-07-05

Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

#95
20070155671
2007-07-05

Diaminopropionic acid derivatives

#96
20070066664
2007-03-22

HIV PROTEASE INHIBITORS, COMPOSITIONS CONTAINING THE SAME, THEIR PHARMACEUTICAL USES, MATERIALS FOR THEIR SYNTHESIS

#97
20070037260
2007-02-15

Process for producing optically active 2-alkycysteine, derivative thereof, and processes for production

#98
20070021354
2007-01-25

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

#99
20060217427
2006-09-28

Cytoskeletal active compounds, compositions and use

#100
20060189589
2006-08-24

2-methylthiazolidine-2,4-dicarboxylic acid and salts thereof for treatment of neurodegenerative diseases

#101
20060154872
2006-07-13

Hemiasterlin derivatives and uses thereof

#102
20060040998
2006-02-23

Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof

#103
20060035884
2006-02-16

N-cyclic sulfonamido inhibitors of gamma secretase

#104
20060030553
2006-02-09

Cell adhesion inhibitors

#105
20060014740
2006-01-19

Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof

#106
20050261290
2005-11-24

Novel compounds of proline and morpholine derivatives

#107
20050256166
2005-11-17

Nitrogen-containing compounds

#108
20050250707
2005-11-10

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

#109
20050245432
2005-11-03

N-methyl amino acids

#110
20050215605
2005-09-29

Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor

#111
20050181443
2005-08-18

Coreactant-including electrochemiluminescent compounds, methods, systems and kits utilizing same

#112
20050171166
2005-08-04

Substituted 5-membered n-heterocyclic compounds and their uses for treating or preventing neurodegenerative diseases

#113
20050153973
2005-07-14

Compounds

#114
20050148641
2005-07-07

2-Methylthiazolidine-2,4-Dicarboxylic acid and salts thereof for the treatment of neurodegenerative diseases

#115
20050148637
2005-07-07

Heterocyclic ketone and thioester compounds and uses

#116
20050148623
2005-07-07

HIV protease inhibiting compounds

#117
20050148588
2005-07-07

LFA-1 antagonist compounds

#118
20050129772
2005-06-16

Compositions comprising an HIV protease inhibitor

#119
20050124683
2005-06-09

HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis

#120
20050124673
2005-06-09

Methods of preparing compounds useful as protease inhibitors

#121
20050096348
2005-05-05

DPP IV inhibitors

#122
20050080119
2005-04-14

Diaminopropionic acid derivatives

#123
20050070719
2005-03-31

Inhibitors of dipeptidyl peptidase iv

#124
20050009890
2005-01-13

Amino acid derivatives and pharmaceutical composition comprising, as active ingredients, them

#125
14987586
2016-09-20

α-amino esters of hydroxypropylthiazolidine carboxamide derivative and salt form, crystal polymorph thereof